Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Genes & Diseases|February 12, 2020
PRMT5 in gene regulation and hematologic malignanciesFen Zhu, Lixin Rui
Leukemia & Lymphoma|April 13, 2017
HiJAKing the epigenome in leukemia and lymphomaAmanda C Drennan, Lixin Rui
Current Molecular Medicine|May 23, 2006
Lymphoma and the control of B cell growth and differentiationLixin Rui, Christopher C Goodnow
Journal of Genetics and Genomics = Yi Chuan Xue Bao|September 30, 2020
DNA methyltransferases in hematological malignanciesNguyet-Minh Hoang, Lixin Rui
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2016
Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodiesChristopher G England, Lixin Rui, Weibo Cai
Cancers|December 22, 2019
STAT3 Activation and Oncogenesis in LymphomaFen Zhu, Kevin Boyang Wang, Lixin Rui
Molecular Cancer Research : MCR|December 30, 2016
Nuclear Import of JAK1 Is Mediated by a Classical NLS and Is Required for Survival of Diffuse Large B-cell LymphomaFen Zhu, Byounghoon Hwang, Shigeki Miyamoto, et al.
Nature Immunology|September 22, 2011
Malignant pirates of the immune systemLixin Rui, Roland Schmitz, Michele Ceribelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiationLixin Rui, James I Healy, Julie Blasioli, et al.
Nature Immunology|May 13, 2003
Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signalingLixin Rui, Carola G Vinuesa, Julie Blasioli, et al.
Pageof 4